Rein Therapeutics (RNTX) Proxy Filing summary

Executive summary

• Annual meeting adjourned to July 23, 2025, due to lack of quorum on June 24, 2025.

• Record date for voting remains May 5, 2025.

• Meeting will reconvene virtually at 9:00 a.m. Eastern Time.

Voting matters and shareholder proposals

• All proposals from the original proxy statement remain up for vote at the reconvened meeting.

• Shareholders are encouraged to vote, and previously submitted proxies remain valid unless changed.

Board of directors and corporate governance

• Board approved an amendment to the by-laws reducing the quorum requirement for shareholder meetings.

• New quorum is 40% of outstanding shares, down from a majority.